What’s new and noteworthy on CDRH’s FY2024 guidance agenda

FDA’s Center for Devices and Radiological Health (CDRH), the agency’s medical device regulatory division, today released its latest “guidance agenda” detailing the documents it plans to release in FY2024. AgencyIQ analyzed the agenda, which features an ambitious and topical array of new and old issues, including some that could have significant impacts on specific medical device sectors.

Fill out the form to read the full article.

Required *

Copy link
Powered by Social Snap